ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,619Medicare Part D Prescriptions Filled, Including Refills

Rank: 517 out of 1456

$462K Total Retail Price of All Prescriptions

Rank: 490 out of 1456

451 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 451 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

6% of this provider’s 451 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 5,758 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
AMLODIPINE BESYLATE 423 372 1 1
SIMVASTATIN 410 334 2 2
LISINOPRIL 335 262 3 3
HYDROCHLOROTHIAZIDE 274 205 4 10
METFORMIN HCL 225 152 5 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 201 124 6 24
OMEPRAZOLE 173 130 7 5
METOPROLOL TARTRATE 168 144 8 12
METOPROLOL SUCCINATE 155 131 9 19
FUROSEMIDE 136 105 10 7
PRAVASTATIN SODIUM 125 73 11 9
CLONIDINE HCL 123 77 12 39
CARVEDILOL 104 82 13 20
GABAPENTIN 102 65 14 13
ALLOPURINOL 96 69 15 31
LANTUS 91 77 16 50
ATORVASTATIN CALCIUM 84 70 17 11
LEVOTHYROXINE SODIUM 83 47 18 4
DIOVAN 82 77 19 35
TRAMADOL HCL 80 64 20 17
HYDRALAZINE HCL 73 60 21 48
DONEPEZIL HCL 71 71 22 29
GLIMEPIRIDE 71 52 22 33
HYDROCODONE-ACETAMINOPHEN 70 54 S3 24 6
CLOPIDOGREL 69 65 25 32
GLYBURIDE-METFORMIN HCL 67 56 R 26 119
DOXAZOSIN MESYLATE 67 52 26 84
TAMSULOSIN HCL 64 64 28 34
NIFEDIPINE ER 64 55 28 81
PLAVIX 63 61 30 46
IBUPROFEN 62 34 31 103
RANITIDINE HCL 62 47 31 27
LOSARTAN POTASSIUM 61 41 33 16
ADVAIR DISKUS 60 55 34 63
LOSARTAN-HYDROCHLOROTHIAZIDE 59 50 35 41
GLIPIZIDE 58 46 36 53
NEXIUM 58 42 36 23
ATENOLOL 57 31 38 18
COLCRYS 53 43 39 122
NAMENDA 50 42 40 38
PEN NEEDLE 50 37 40 131
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.